We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
576
Infosys
INFY
$51.1B
| $98K | ﹤0.01% |
5,280
| – | – |
2022 Q1
7 quarters
|
|
577
Gabelli Equity Trust 5.00% Series H Preferred Stock
GAB.PRH
$77.2M
| $97K | ﹤0.01% |
4,500
| – | – |
2022 Q1
7 quarters
|
|
578
Rivian
RIVN
$18.2B
| $97K | ﹤0.01% |
4,100
-150
| -4% | -$2.82K |
2022 Q1
7 quarters
|
|
579
Plains GP Holdings
PAGP
$5.47B
| $95K | ﹤0.01% |
6,000
| – | – |
2023 Q2
2 quarters
|
|
580
Essential Utilities
WTRG
$11.6B
| $95K | ﹤0.01% |
2,531
| – | – |
2022 Q1
7 quarters
|
|
581
DELISTED
Coterra Energy
CTRA
| $93K | ﹤0.01% |
3,620
| – | – |
2022 Q1
7 quarters
|
|
582
Northrop Grumman
NOC
$76.9B
| $93K | ﹤0.01% |
200
| – | – |
2022 Q1
7 quarters
|
|
583
Schwab International Small-Cap Equity ETF
SCHC
$5.55B
| $93K | ﹤0.01% |
2,650
-354
| -12% | -$11.5K |
2022 Q1
7 quarters
|
|
584
iShares ESG Aware MSCI EM ETF
ESGE
$6.52B
| $92K | ﹤0.01% |
2,875
| – | – |
2022 Q1
7 quarters
|
|
585
Knife River
KNF
$2.92B
| $92K | ﹤0.01% |
1,375
| – | – |
2023 Q2
2 quarters
|
|
586
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.1B
| $91K | ﹤0.01% |
627
+320
| +104% | +$43K |
2020 Q2
14 quarters
|
|
587
Schwab US REIT ETF
SCHH
$10.9B
| $90K | ﹤0.01% |
4,301
+1,570
| +57% | +$29.2K |
2022 Q4
4 quarters
|
|
588
Ameren
AEE
$29.5B
| $89K | ﹤0.01% |
1,229
| – | – |
2022 Q1
7 quarters
|
|
589
Invesco S&P 500 Equal Weight ETF
RSP
$100B
| $88K | ﹤0.01% |
558
+280
| +101% | +$40.7K |
2022 Q2
6 quarters
|
|
590
BP
BP
$128B
| $87K | ﹤0.01% |
2,465
+1
| +0% | +$37 |
2022 Q1
7 quarters
|
|
591
DELISTED
Hess
HES
| $87K | ﹤0.01% |
600
| – | – |
2023 Q2
2 quarters
|
|
592
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.16B
| $86K | ﹤0.01% |
3,000
+2,000
| +200% | +$51.1K |
2023 Q2
2 quarters
|
|
593
Roper Technologies
ROP
$39.1B
| $86K | ﹤0.01% |
157
+27
| +21% | +$13.9K |
2022 Q1
7 quarters
|
|
594
General Motors
GM
$67.1B
| $85K | ﹤0.01% |
2,341
+46
| +2% | +$1.42K |
2013 Q2
42 quarters
|
|
595
Jacobs Solutions
J
$16.5B
| $85K | ﹤0.01% |
786
-60
| -7% | -$6.53K |
2022 Q1
7 quarters
|
|
596
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.5B
| $83K | ﹤0.01% |
+1,041
| New | +$76.4K |
2023 Q4
0 quarters
|
|
597
ProShares Ultra Health Care
RXL
$104M
| $83K | ﹤0.01% |
1,824
| – | – |
2022 Q1
7 quarters
|
|
598
Texas Roadhouse
TXRH
$11B
| $83K | ﹤0.01% |
680
| – | – |
2022 Q1
7 quarters
|
|
599
WisdomTree US LargeCap Dividend Fund
DLN
$6.34B
| $82K | ﹤0.01% |
1,233
-666
| -35% | -$41.8K |
2022 Q1
7 quarters
|
|
600
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
| $82K | ﹤0.01% |
1,058
| – | – |
2022 Q1
7 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.